As of Oct 19
| -1.95 / -1.58%|
The 9 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 130.00, with a high estimate of 156.00 and a low estimate of 92.00. The median estimate represents a +6.91% increase from the last price of 121.60.
The current consensus among 9 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.